Trial
NCT00758342
Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Alcon Research
Collaborators
—
Condition
Intraocular Pressure
Intervention
Travoprost 0.004% + Brinzolamide 1.0%
Why stopped
difficulty of enrolling patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-12-05